Drug Updates

Dr. Moopen’s Family Fortifies Investment in Aster DM Healthcare with 4% Stake Increase

The Moopen family, promoters of Aster DM Healthcare, has raised their stake in the India-listed company by 4%, from 37.88% to 41.88%. This expansion was achieved by acquiring additional shares worth Rs 460 Crore (Dh. 207 million) from a prominent private equity investor.

Dr. Azad Moopen, the Founder Chairman and Managing Director, emphasized the family’s commitment to the business, its patients, and employees. Aster DM Healthcare, with a revenue of Rs. 10,253 crore in FY 2021-22, is experiencing significant growth due to restructuring efforts in India and GCC.

The company has numerous upcoming projects in India and is expanding its presence in the GCC with new hospitals and pharmacies. The myAster App, already boasting 352,000+ downloads, will connect all facilities, providing an omnichannel healthcare experience.


Leave a Reply

Your email address will not be published. Required fields are marked *